Download PDF
Thromb Haemost 1990; 64(03): 488-489
DOI: 10.1055/s-0038-1647344
Letter to the Editor
Schattauer GmbH Stuttgart

Auto-lmmune Eactor Vlll : G lnhibitor Durably Responsive to lmmunoglobulin: A New Case

F Lionnet
*   Department of Internal Medicine Henri Mondor Hospital, 94010 Creteil, France
,
M Gouault-Heilmann
**   Heamostasis Laboratory Henri Mondor Hospital, 94010 Creteil, France
,
C Azoulay
*   Department of Internal Medicine Henri Mondor Hospital, 94010 Creteil, France
,
J M Lacorte
**   Heamostasis Laboratory Henri Mondor Hospital, 94010 Creteil, France
,
A Schaeffer
*   Department of Internal Medicine Henri Mondor Hospital, 94010 Creteil, France
› Author Affiliations
Further Information

Publication History

Received 05 April 1990

Accepted after revision 27 June 1990

Publication Date:
25 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Sultan Y, Kazatchkine MD, Maisonneuve P, Nydegger WE. Anti-idiotypic suppression of autoantibodies to factor VIII (anti-haemophilic factor) by high-dose intravenous gammaglobulin. Lancet 1984; ii: 765-768
    PubMedGoogle Scholar
  • 2 Sultan Y, Rossi F, Kazatchkine MD. Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C auto-antibodies. Proc Natl Acad Sci USA 1987; 84: 828-831
    CrossrefPubMedGoogle Scholar
  • 3 Carreras LO, Perez GN, Xavier DL, Blanco AN, Pevalva LB. Autoimmune factor VIII inhibitor responsive to gammaglobulin without in vitro neutralisation. Thromb Haemostas 1988; 60: 343
    PubMedGoogle Scholar
  • 4 Green D, Kwaan HC. An acquired factor VIII inhibitor responsive to high dose gammaglobulin. Thromb Haemostas 1987 58. 521 (Abstr).
    PubMedGoogle Scholar
  • 5 Hiller E, Holler E, Gemsen RG, Riess H. Successfull treatment with high dose intravenous immunoglobulin in a patient with spontaneous inhibitor to factor VIII. Blut 1986; 52: 123-126
    CrossrefPubMedGoogle Scholar
  • 6 Zimmerman R, Kommerell B, Harenberg J, Eich W, Rother K, Schimpf RI. Intravenous IgG for patients with spontaneous inhibitor to factor VIII. Lancet 1985; i: 273-274
    PubMedGoogle Scholar
  • 7 Green D, Lechner K. A survey of 215 non-hemophiliac patients with inhibitors to factor VIII. Thromb Haemostas 1981; 45: 200-203
    PubMedGoogle Scholar
  • 8 Hultin MB, Shapiro SS, Bowman HS, Gill FM, Andrews AT, Martinez J, Eyster ME, Sherwood WC. Immunosuppressive therapy of factor VIII inhibitors. Blood 1976; 48: 95-108
    PubMedGoogle Scholar
  • 9 Lian EC J, Larcada AF, Chin AY Z. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann Intern Med 1989; 110: 774-778
    CrossrefPubMedGoogle Scholar
  • 10 Green D. Acquired inhibitors of blood coagulation. In: Haemostasis and Thrombosis Bloom AL, Thomas DP. (eds). 2d Ed., Churchill, Livingstone: 1987: 542-553